These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families. Peric B; Cerkovnik P; Novakovic S; Zgajnar J; Besic N; Hocevar M BMC Med Genet; 2008 Sep; 9():86. PubMed ID: 18803811 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations. Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189 [TBL] [Abstract][Full Text] [Related]
4. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752 [TBL] [Abstract][Full Text] [Related]
5. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529 [TBL] [Abstract][Full Text] [Related]
6. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. Della Torre G; Pasini B; Frigerio S; Donghi R; Rovini D; Delia D; Peters G; Huot TJ; Bianchi-Scarra G; Lantieri F; Rodolfo M; Parmiani G; Pierotti MA Br J Cancer; 2001 Sep; 85(6):836-44. PubMed ID: 11556834 [TBL] [Abstract][Full Text] [Related]
7. [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis]. Soufir N; Basset-Seguin N Bull Cancer; 2001 Nov; 88(11):1061-7. PubMed ID: 11741799 [TBL] [Abstract][Full Text] [Related]
9. Genetics of pigmentation and melanoma predisposition. Pho LN; Leachman SA G Ital Dermatol Venereol; 2010 Feb; 145(1):37-45. PubMed ID: 20197744 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition. Wadt KA; Aoude LG; Krogh L; Sunde L; Bojesen A; Grønskov K; Wartacz N; Ek J; Tolstrup-Andersen M; Klarskov-Andersen M; Borg Å; Heegaard S; Kiilgaard JF; Hansen TV; Klein K; Jönsson G; Drzewiecki KT; Dunø M; Hayward NK; Gerdes AM PLoS One; 2015; 10(3):e0122662. PubMed ID: 25803691 [TBL] [Abstract][Full Text] [Related]
11. CDKN2A mutations in melanoma families from Uruguay. Larre Borges A; Cuéllar F; Puig-Butillé JA; Scarone M; Delgado L; Badenas C; Milà M; Malvehy J; Barquet V; Núñez J; Laporte M; Fernández G; Levrero P; Martínez-Asuaga M; Puig S Br J Dermatol; 2009 Sep; 161(3):536-41. PubMed ID: 19523171 [TBL] [Abstract][Full Text] [Related]
12. The genetics of susceptibility to cutaneous melanoma. Newton Bishop JA; Bishop DT Drugs Today (Barc); 2005 Mar; 41(3):193-203. PubMed ID: 15883616 [TBL] [Abstract][Full Text] [Related]
13. Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF. Mangas C; Potrony M; Mainetti C; Bianchi E; Carrozza Merlani P; Mancarella Eberhardt A; Maspoli-Postizzi E; Marazza G; Marcollo-Pini A; Pelloni F; Sessa C; Simona B; Puig-Butillé JA; Badenas C; Puig S Br J Dermatol; 2016 Nov; 175(5):1030-1037. PubMed ID: 27473757 [TBL] [Abstract][Full Text] [Related]
14. Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases. Levanat S; Situm M; Crnić I; Marasović D; Puizina-Ivić N; Pokupcić N; Musani V; Komar A; Kubat M; Furac I; Karija-Vlahović M; Krizanac S Croat Med J; 2003 Aug; 44(4):418-24. PubMed ID: 12950144 [TBL] [Abstract][Full Text] [Related]
15. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma. Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535 [TBL] [Abstract][Full Text] [Related]
16. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain. de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244 [TBL] [Abstract][Full Text] [Related]
18. Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations. Vignoli M; Scaini MC; Ghiorzo P; Sestini R; Bruno W; Menin C; Gensini F; Piazzini M; Testori A; Manoukian S; Orlando C; D'Andrea E; Bianchi-Scarrà G; Genuardi M Melanoma Res; 2008 Dec; 18(6):431-7. PubMed ID: 19011513 [TBL] [Abstract][Full Text] [Related]
19. Genetic variations of patients with familial or multiple melanoma in Southern Brazil. Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339 [TBL] [Abstract][Full Text] [Related]
20. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection. Wang H; Presland RB; Piepkorn M Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]